|
Volumn 55, Issue 1422, 2013, Pages 62-63
|
Dabrafenib (Tafinlar) and Trametinib (Mekinist) for metastatic melanoma
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
B RAF KINASE;
DABRAFENIB;
DACARBAZINE;
IPILIMUMAB;
MEKINIST;
MITOGEN ACTIVATED PROTEIN KINASE 1;
PACLITAXEL;
TAFINLAR;
TRAMETINIB;
UNCLASSIFIED DRUG;
VEMURAFENIB;
ALOPECIA;
ARTHRALGIA;
CARDIOMYOPATHY;
CELL PROLIFERATION;
DIARRHEA;
DISEASE COURSE;
DRUG WITHDRAWAL;
FEVER;
HAND FOOT SYNDROME;
HEADACHE;
HUMAN;
HYPERKERATOSIS;
INTERSTITIAL LUNG DISEASE;
IRITIS;
LETTER;
LYMPHEDEMA;
METASTATIC MELANOMA;
PAPILLOMA;
PROGRESSION FREE SURVIVAL;
RANDOMIZED CONTROLLED TRIAL (TOPIC);
RASH;
RECOMMENDED DRUG DOSE;
RETINA VEIN OCCLUSION;
SKIN CARCINOMA;
UVEITIS;
ANTINEOPLASTIC AGENTS;
HUMANS;
IMIDAZOLES;
MELANOMA;
OXIMES;
PYRIDONES;
PYRIMIDINONES;
|
EID: 84881037448
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Letter |
Times cited : (7)
|
References (8)
|